Life Sciences Tools & Services Companies By Current Ratio

Current Ratio
Current RatioEfficiencyMarket RiskExp Return
1SEER Seer Inc
31.07
 0.07 
 2.70 
 0.19 
2AZTA Azenta Inc
13.21
 0.03 
 3.67 
 0.11 
3QTRX Quanterix Corp
11.27
(0.02)
 4.65 
(0.10)
4PACB Pacific Biosciences of
11.19
 0.04 
 5.02 
 0.19 
5BNGO Bionano Genomics
7.75
(0.09)
 7.62 
(0.72)
6MRVI Maravai Lifesciences Holdings
7.22
 0.08 
 5.66 
 0.46 
7PSNL Personalis
6.26
 0.03 
 5.11 
 0.15 
8CGEN Compugen
6.16
(0.09)
 2.67 
(0.23)
9LAB Standard Biotools
5.87
 0.08 
 3.41 
 0.28 
10TXG 10X Genomics
5.65
 0.07 
 3.74 
 0.25 
11BIO Bio Rad Laboratories
5.5
 0.10 
 3.02 
 0.30 
12CDXS Codexis
4.84
 0.02 
 4.48 
 0.10 
13ADPT Adaptive Biotechnologies Corp
3.93
 0.10 
 3.04 
 0.29 
14TECH Bio Techne Corp
3.44
 0.03 
 2.74 
 0.07 
15MLAB Mesa Laboratories
2.9
(0.06)
 5.17 
(0.31)
16SHC Sotera Health Co
2.81
 0.18 
 3.65 
 0.65 
17BRKR Bruker
2.55
(0.07)
 3.96 
(0.28)
18HBIO Harvard Bioscience
2.42
 0.02 
 5.57 
 0.11 
19RGEN Repligen
2.3
 0.02 
 2.93 
 0.07 
20WAT Waters
2.1
(0.08)
 2.57 
(0.21)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company. Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).